• Journal of the Korean Data and Information Science Society
• /
• 제12권2호
• /
• pp.71-82
• /
• 2001

There are several ways to test the equality of two survival distributions under a variety of situations. Tests for equality of two distributions with life-table model for univariate independent response times are reviewed and introduced. It is developed that the methodology to test it for correlated response times where treatments are applied to different independent sets of cohorts. Data, which can be separated into two independent sets, from an angioplasty study where more than one procedure is performed on some patients are used to illustrate this methodology.

• Journal of Chest Surgery
• /
• 제32권12호
• /
• pp.1123-1126
• /
• 1999

Coronary artery bypass grafting (CABG) technique has been much developed but CABG under cardiopulmonary bypass has the unavoidable deficits such as generalized inflammatory reaction from cardiopulmonary bypass and myocardial ischemia from aortic-cross clamp. There has been remarkable advancement of CABG without cadiopulmonary bypass. We performed CABG successfully without cardiopulmonary bypass. We performed CABG successfully without cardiopulmonary bypass in two patients with multivessel coronary disease who were failed to intervene with percutaneous transluminal coronary angioplasty. We herein report the two cases.

• Journal of Chest Surgery
• /
• 제36권3호
• /
• pp.202-205
• /
• 2003

중심정맥혈전증은 흔히 관찰되는 질병이다. 그러나 그 원인 중 오른총장골정맥이 왼총장골동맥의 눌림과 협착에 의해 정맥 흐름이 방해받는 경우가 드물게 있으며, 이를 May-Thurner 증후군 또는 장골눌림증후군(Iliac compression syndrome)이라 한다. 이에 대한 치료는 중심정맥혈전증이 있을 경우에 카테터를 이용한 혈전 용해술과 혈전 용해 후 왼총장골정맥 내 스텐트(Stent) 삽입이 추천되고 있다. 저자들은 좌측 하지 부종으로 내원하여 시행한 정맥조영술상 May-Thurner syndrome으로 진단된 2예에서 혈전용해술 및 풍선확장술과 왼총장골정맥 내에 스텐트를 삽입하여 성공적으로 치료하였기에 관련 문헌과 함께 보고하는 바이다.

• 한국정보통신학회논문지
• /
• 제15권9호
• /
• pp.2013-2018
• /
• 2011

관상동맥 성형술과 관상동맥 우회술은 심근경색의 치료를 위해서 널리 이용되고 있는 방법이다. 특히 이 시술을 위해서 혈관의 협착 부위를 정확히 진단하는데 많은 어려움이 있다. 이러한 문제점을 개선하기 위해서 여러 연구자들에 의해서 에지 추출을 이용한 혈관의 협착부위를 검출하는 연구가 진행되고 있다. 그러나 이러한 방법들은 혈관의 구조나 영상의 질에 따라 그 성능의 차이가 발생한다. 따라서 본 연구는 이러한 문제점을 개선하기 위해 새로운 알고리즘을 제안한다. 제안된 알고리즘은 다중 샘플링과 쓰레쉬홀드, 퍼지 알고리즘을 이용한 혈관의 분기점과 끝점, 협착 부위를 검출하는 방법으로 구성되어 있다. 제안된 알고리즘의 성능을 평가하기 위해 다양한 혈관조영영상을 사용하였으며 그 결과 제안된 알고리즘에 의한 혈관의 분기점 및 끝점, 협착 부위 검출에 효과적이었다.

• Journal of Chest Surgery
• /
• 제49권sup1호
• /
• pp.60-67
• /
• 2016

Background: Coronary angioplasty has been replacing coronary artery bypass grafting (CABG) because of the relative advantage in terms of recovery time and noninvasiveness of the procedure. Compared to other Organization for Economic Cooperation and Development (OECD) countries, Korea has experienced a rapid increase in coronary angioplasty volumes. Methods: We analyzed changes in procedure volumes of CABG and of percutaneous coronary intervention (PCI) from three sources: the OECD Health Data, the National Health Insurance Service (NHIS) surgery statistics, and the National Health Insurance claims data. Results: We found the ratio of procedure volume of PCI to that of CABG per 100,000 population was 19.12 in 2014, which was more than triple the OECD average of 5.92 for the same year. According to data from NHIS statistics, this ratio was an increase from 11.4 to 19.3 between 2006 and 2013. Conclusion: We found that Korea has a higher ratio of total procedure volumes of PCI with respect to CABG and also a more rapid increase of volumes of PCI than other countries. Prospective studies are required to determine whether this increase in absolute volumes of PCI is a natural response to a real medical need or representative of medical overuse.

• Journal of Yeungnam Medical Science
• /
• 제34권2호
• /
• pp.242-246
• /
• 2017

Acute limb ischemia (ALI) due to an embolism is associated with high mortality rate and poor prognosis, and early diagnosis with prompt revascularization is required to reduce the risk of limb amputation or even death. The etiologies of ALI are diverse, and it includes an embolism from the heart and thrombotic occlusion of the atherosclerotic native vessels, stents, or grafts. An uncommon cause of ALI is acute arterial thromboembolism, and atrial fibrillation (AF) is the single most important risk factors for systemic thromboembolism. It is important to correctly identify the source of ALI for secondary prevention, as it depends on the underlying cause. Percutaneous transluminal angioplasty (PTA) has been proven to be a safe and effective treatment for focal atherosclerotic and thrombotic occlusive diseases of the aorta and its major extremity branches. Herein, we report on a 77-year-old female patient with acute upper limb ischemia, treated by PTA using a catheter-guided thrombectomy. He was newly diagnosed with paroxysmal AF (PAF) while evaluation the cause of his acute arterial thromboembolism. We recommend that cardiologists always consider PAF as a possible diagnosis even in patients without any history of AF under ALI because it is possible to develop thromboembolism in clinical practice.

• Journal of Chest Surgery
• /
• 제30권1호
• /
• pp.34-39
• /
• 1997

1994년 5월부터 1995년 12월까지 성인에서 심장수술을 시행한 122례중 18례(14.8%)에서 IABP를 순환보조장치로 사용하였다. 그중 술전에 IABP(intra-aortic balloon pump)를 시행한 경우는 9례이고, 술 중에는 7례, 그리고 술후에는 2례에서 시행하였다. 그 이유는 술전에는 저심박출, PTCA(percutaneous transluminal coronary angioplasty)의 실패였고, 술중에는 체외순환기 이탈을 위해서이며, 술후에는 술후 발생한 부정 맥 때문이었다. 환자들의 평균 나이는 61.8$\pm$6.9세(39세에서 75세)였다. 술전 및 술중에 IABP를 시행한 환자의 수술사망율은 각각 33.3, 42.9%였으며 술후 IABP를 시행한 환자는 모두 생존하였다. IABP이탈율은 술전의 경우 66.77%. 술중의 경우 85.7%였으며 술후에 시행한 IABP는 모두 이탈 가능하였다. 결론적으로 IABP는 심근 손상이 가역적인 시기에 적용할 경우, 수술전후 어느시기에나 안전하게 사용가능하며 수술전후의 혈류역학적 불안정, 체외순환기 이탈 및 저심박출증의 치료에 도움을 줄 수 있다고 판단된다.

• 약학회지
• /
• 제55권2호
• /
• pp.116-120
• /
• 2011

Abnormal proliferation of vascular smooth muscle cells (VSMCs) plays an important role in the development and progression of proliferative cardiovascular diseases, including hypertension and atherosclerosis. To find antiproliferative agent (A)-8 had inhibitory effect on VSMCs proliferation. Therefore, we examined the antiproliferative effect of A-8, a newly synthesized obovatol derivative. To investigate the antiproliferative effect of A-8, we examined cell counting and [$^3H$]-thymidine incorporation assays. The pre-incubation of A-8 (1~4 ${\mu}M$) significantly inhibited proliferation and DNA synthesis of 5% fetal bovine serum (FBS)-stimulated rat aortic VSMCs in concentration-dependent manner. Whereas, A-8 did not show any cytotoxicity in rat aortic VSMCs in this experimental condition by WST-1 assay. In addition, A-8 significantly inhibited 5% FBS-induced cell cycle progression in rat aortic VSMCs. These results show that A-8 may be developed as a potential antiproliferative agent for treatment of angioplasty restenosis and atherosclerosis. Furthermore, A-8 should be examined for further clinical application either as a single agent or in combination with other angioplasty restenosis or atherosclerosis agents.

• The Korean Journal of Physiology and Pharmacology
• /
• 제19권5호
• /
• pp.421-426
• /
• 2015

The increased potential for vascular smooth muscle cell (VSMC) growth is a key abnormality in the development of atherosclerosis and post-angioplasty restenosis. Abnormally high activity of platelet-derived growth factor (PDGF) is believed to play a central role in the etiology of these pathophysiological situations. Here, we investigated the anti-proliferative effects and possible mechanism(s) of murrayafoline A, a carbazole alkaloid isolated from Glycosmis stenocarpa Guillamin (Rutaceae), on PDGF-BB-stimulated VSMCs. Murrayafoline A inhibited the PDGF-BB-stimulated proliferation of VSMCs in a concentration-dependent manner, as measured using a non-radioactive colorimetric WST-1 assay and direct cell counting. Furthermore, murrayafoline A suppressed the PDGF-BB-stimulated progression through $G_0/G_1$ to S phase of the cell cycle, as measured by [$^3H$]-thymidine incorporation assay and cell cycle progression analysis. This anti-proliferative action of murrayafoline A, arresting cell cycle progression at $G_0/G_1$ phase in PDGF-BB-stimulated VSMCs, was mediated via down-regulation of the expression of cyclin D1, cyclin E, cyclin-dependent kinase (CDK)2, CDK4, and proliferating cell nuclear antigen (PCNA), and the phosphorylation of retinoblastoma protein (pRb). These results indicate that murrayafoline A may be useful in preventing the progression of vascular complications such as restenosis after percutaneous transluminal coronary angioplasty and atherosclerosis.

• Journal of Chest Surgery
• /
• 제23권3호
• /
• pp.474-481
• /
• 1990

We have experienced 44 cases of coarctation of aorta in the age of infancy and children from April 1986 to September 1989 at Seoul National University Children`s hospital. Patients were thirty males and fourteen females, and their age ranged from one month to ten years[mean 23.84 $\pm$33.06 months] with thirty-two infant cases. In the infantile age, congestive heart failure was the most common chief complaint[18/32], and above that age, frequent upper respiratory infection was most common[8/12]. We experienced thirteen cases of isolated COA, twenty-two cases of COA with VSD, eight cases of COA with VSD, eight cases of COA with intracardiac complex anomalies and one case of COA with atrial septal defect. The associated intracardiac complex anomalies were three Taussig-Bing type double outlet right ventricle, one single ventricle, one transposition of great arteries, one atrioventricular septal defect, one hypoplastic aortic arch with left heart hypoplasia, and one Tetralogy of Fallot. Operative techniques of COA were twenty-three subclavian flap arterioplasty, 12 resection and end to end anastomosis, eight onlay patch angioplasty, and I direct angioplasty after resection of web. Among the cases with other cardiac anomalies, staged operation was done in twenty-nine patients, and single stage total correction was performed only in three patients. There were seven operative mortality[15.9%], all being in infantile age group, and among fourteen cases associated with large VSD[Qp/Qs>2.0, mean pulmonary arterial pressure>50mmHg], four patients were died, but there was no mortality in patients with small VSD. With above results, we are intended to discuss about the interval between staged operation, the fate of VSD after coarctoplasty in case of COA with VSD, causes of death, complications etc.